Gerber Kawasaki Wealth & Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
SCM
BCM
CS
PI
Gerber Kawasaki Wealth & Investment Management's IRWD Position: Q4 2021 in Review
Gerber Kawasaki Wealth & Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 2 shares — an estimated $2K sold.
Gerber Kawasaki Wealth & Investment Management first reported a position in IRWD in Q4 2015 and held it in 18 quarters. The position peaked at $238K in Q4 2020. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.
- Gerber Kawasaki Wealth & Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Gerber Kawasaki Wealth & Investment Management sold 2 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $2K.
- Gerber Kawasaki Wealth & Investment Management first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 18 quarters.
- Gerber Kawasaki Wealth & Investment Management's Ironwood Pharmaceuticals position peaked at $238K in Q4 2020.
- 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.
Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.